Mindmed appoints robert barrow as chief executive officer and director

-mr. barrow previously served as interim chief executive officer and chief development officer of mindmed -carol vallone appointed as chair of the board of directors, andreas krebs appointed as vice chair and perry dellelce transitions from his role as chairman- new york, dec. 14, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, today announced that robert barrow was appointed as chief executive officer and as a member of the board of directors, effective immediately. mr. barrow previously served as interim chief executive officer and chief development officer of mindmed and brings strategic expertise and deep industry insight to his role.
MNMD Ratings Summary
MNMD Quant Ranking